ABT-046 is a potent, selective, and orally active acyl CoA:diacylglycerol acyltransferase 1 ( DGAT-1 ) inhibitor with IC 50 s of both 8 nM against human and mouse DGAT-1.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Obesity | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Acyltransferase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.